EUCTR2011-003297-81-SE进行中（未招募）不适用
A prospective, randomized study on intravitreal Ozurdex for preventing recurrent vitreous hemorrhage following pars plana vitrectomy for proliferative diabetic retinopathy
St Eriks Eye Hospital0 个研究点开始时间: 2011年7月20日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Patients undergoing PPV for PDRP
- •Reoperation will be performed on patients with persistent or recurrent vitreous hemorrhage that have not cleared after one month
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range: 5
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 60
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 35
排除标准
- •Previous PPV
- •Vitreous hemorrhage of non-PDRP origin
研究者
相似试验
招募中
不适用
Clinical study of the use of Bevacizumab in glaucoma surgery.RBR-9wkw73jnião Metropolitana de Educação e Cultura
进行中（未招募）
不适用
Evaluation of safety and efficacy of intravitreal bevacizumab for macular edema, retinal or choroidal neovascularization or neovascular glaucoma - NDMacular oedemaMedDRA version: 6.1Level: HLGTClassification code 10047060EUCTR2006-002351-33-ITAZIENDA OSPEDALIERA ISTITUTI OSPITALIERI DI VERONA
进行中（未招募）
1 期
A Pilot Study Evaluating the Effect of Intravitreal Fluocinolone Acetonide (0.19mg) in Patients with Retinitis Pigmentosa.Retinitis Pigmetosa.MedDRA version: 19.0 Level: PT Classification code 10038914 Term: Retinitis pigmentosa System Organ Class: 10010331 - Congenital, familial and genetic disordersEUCTR2016-002523-28-GBMoorfields Eye Hospital1
已完成
不适用
Rondomized prospective trials of intravitreal bevacizumab alone versus combined with photocoagulation for ischmic lesion in retinal venous occlusion.macular edema due to branch retinal vein occlusionJPRN-UMIN000009689Department of Ophthalmology, Faculty of Medical Sciences, University of Fukui40
进行中（未招募）
不适用
Randomised controlled trial of intravitreal Bevacizumab vs. conventional treatment for rubeotic glaucoma. - Randomised controlled trial of intravitreal Bevacizumab vs. conventional treatment for rubeotic glauRubeotic glaucoma secondary to ischaemic proliferative retinopathiesEUCTR2007-000585-21-IERoyal Victoria Eye and Ear hospital20